Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05255471
Title MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. (MITO 35B)
Acronym MITO 35B
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute, Naples
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.